Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Silencing p75(NTR) prevents proNGF-induced endothelial cell death and development of acellular capillaries in rat retina.

Shanab AY, Mysona BA, Matragoon S, El-Remessy AB.

Mol Ther Methods Clin Dev. 2015 May 6;2:15013. doi: 10.1038/mtm.2015.13. eCollection 2015.

2.

Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.

Mysona BA, Matragoon S, Stephens M, Mohamed IN, Farooq A, Bartasis ML, Fouda AY, Shanab AY, Espinosa-Heidmann DG, El-Remessy AB.

Biomed Res Int. 2015;2015:571456. doi: 10.1155/2015/571456. Epub 2015 Mar 17.

3.

MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes.

Fulzele S, El-Sherbini A, Ahmad S, Sangani R, Matragoon S, El-Remessy A, Radhakrishnan R, Liou GI.

Biomed Res Int. 2015;2015:846501. doi: 10.1155/2015/846501. Epub 2015 Mar 1.

4.

Erratum to: Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.

Mysona BA, Al-Gayyar MM, Matragoon S, Abdelsaid MA, El-Azab MF, Saragovi HU, El-Remessy AB.

Diabetologia. 2015 Mar;58(3):644. doi: 10.1007/s00125-014-3476-5. No abstract available.

PMID:
25527000
5.

Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).

Shanab AY, Elshaer SL, El-Azab MF, Soliman S, Sabbineni H, Matragoon S, Fagan SC, El-Remessy AB.

Angiogenesis. 2015 Apr;18(2):137-50. doi: 10.1007/s10456-014-9451-4. Epub 2014 Nov 25.

6.

Deletion of thioredoxin interacting protein (TXNIP) augments hyperoxia-induced vaso-obliteration in a mouse model of oxygen induced-retinopathy.

Abdelsaid MA, Matragoon S, Ergul A, El-Remessy AB.

PLoS One. 2014 Oct 16;9(10):e110388. doi: 10.1371/journal.pone.0110388. eCollection 2014.

7.

Systemic effects of ophthalmic cyclopentolate on body weight in neonatal mice.

Rozette NA, Matragoon S, Sethi S, Goei S, Manasco KB, El-Remessy AB.

Neonatology. 2014;106(1):37-41. doi: 10.1159/000358228. Epub 2014 Apr 25.

8.

Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury.

El-Azab MF, Baldowski BR, Mysona BA, Shanab AY, Mohamed IN, Abdelsaid MA, Matragoon S, Bollinger KE, Saul A, El-Remessy AB.

Br J Pharmacol. 2014 Mar;171(5):1299-313. doi: 10.1111/bph.12535.

9.

Pronerve growth factor induces angiogenesis via activation of TrkA: possible role in proliferative diabetic retinopathy.

Elshaer SL, Abdelsaid MA, Al-Azayzih A, Kumar P, Matragoon S, Nussbaum JJ, El-Remessy AB.

J Diabetes Res. 2013;2013:432659. doi: 10.1155/2013/432659. Epub 2013 Aug 12.

10.

Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.

Mysona BA, Al-Gayyar MM, Matragoon S, Abdelsaid MA, El-Azab MF, Saragovi HU, El-Remessy AB.

Diabetologia. 2013 Oct;56(10):2329-39. doi: 10.1007/s00125-013-2998-6. Epub 2013 Aug 7. Erratum in: Diabetologia. 2014 Jun;57(6):1268. Diabetologia. 2015 Mar;58(3):644.

11.

Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.

Abdelsaid MA, Matragoon S, El-Remessy AB.

Antioxid Redox Signal. 2013 Dec 20;19(18):2199-212. doi: 10.1089/ars.2012.4761. Epub 2013 Jul 12.

12.

Diabetes and overexpression of proNGF cause retinal neurodegeneration via activation of RhoA pathway.

Al-Gayyar MM, Mysona BA, Matragoon S, Abdelsaid MA, El-Azab MF, Shanab AY, Ha Y, Smith SB, Bollinger KE, El-Remessy AB.

PLoS One. 2013;8(1):e54692. doi: 10.1371/journal.pone.0054692. Epub 2013 Jan 24. Retraction in: PLoS One. 2017 Oct 16;12 (10 ):e0186748.

13.

Alterations of retinal vasculature in cystathionine-Beta-synthase mutant mice, a model of hyperhomocysteinemia.

Tawfik A, Al-Shabrawey M, Roon P, Sonne S, Covar JA, Matragoon S, Ganapathy PS, Atherton SS, El-Remessy A, Ganapathy V, Smith SB.

Invest Ophthalmol Vis Sci. 2013 Feb 1;54(2):939-49. doi: 10.1167/iovs.12-10536.

14.

Electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor causes retinal neuro- and vascular degeneration.

Matragoon S, Al-Gayyar MM, Mysona BA, Abdelsaid MA, Pillai BA, Neet KE, Fagan SC, El-Remessy AB.

Mol Vis. 2012;18:2993-3003. Epub 2012 Dec 14.

15.

Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats.

Mohamed IN, Soliman SA, Alhusban A, Matragoon S, Pillai BA, Elmarkaby AA, El-Remessy AB.

Mol Vis. 2012;18:1457-66. Epub 2012 Jun 2.

16.

Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.

Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB.

Br J Pharmacol. 2011 Sep;164(1):170-80. doi: 10.1111/j.1476-5381.2011.01336.x.

17.

Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes.

Ibrahim AS, El-Remessy AB, Matragoon S, Zhang W, Patel Y, Khan S, Al-Gayyar MM, El-Shishtawy MM, Liou GI.

Diabetes. 2011 Apr;60(4):1122-33. doi: 10.2337/db10-1160. Epub 2011 Feb 11.

18.

Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].

Al-Gayyar MM, Matragoon S, Pillai BA, Ali TK, Abdelsaid MA, El-Remessy AB.

Diabetologia. 2011 Mar;54(3):669-80. doi: 10.1007/s00125-010-1994-3. Epub 2010 Dec 7. Erratum in: Diabetologia. 2011 Mar;54(3):713.

PMID:
21136036
19.

Peroxynitrite mediates diabetes-induced endothelial dysfunction: possible role of Rho kinase activation.

El-Remessy AB, Tawfik HE, Matragoon S, Pillai B, Caldwell RB, Caldwell RW.

Exp Diabetes Res. 2010;2010:247861. doi: 10.1155/2010/247861. Epub 2010 Nov 1.

20.

Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury.

Ali TK, Al-Gayyar MM, Matragoon S, Pillai BA, Abdelsaid MA, Nussbaum JJ, El-Remessy AB.

Diabetologia. 2011 Mar;54(3):657-68. doi: 10.1007/s00125-010-1935-1. Epub 2010 Oct 19.

PMID:
20957344
21.

Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes.

Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB.

Am J Pathol. 2010 Sep;177(3):1187-97. doi: 10.2353/ajpath.2010.091289. Epub 2010 Jul 22. Erratum in: Am J Pathol. 2015 Jun;185(6):1795-6.

22.

Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.

Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB.

J Pharmacol Exp Ther. 2010 Jan;332(1):125-34. doi: 10.1124/jpet.109.157941. Epub 2009 Oct 8.

PMID:
19815813
23.

Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.

El-Remessy AB, Tang Y, Zhu G, Matragoon S, Khalifa Y, Liu EK, Liu JY, Hanson E, Mian S, Fatteh N, Liou GI.

Mol Vis. 2008;14:2190-203. Epub 2008 Dec 3. Retraction in: Mol Vis. 2014;20:1227.

24.

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

Al-Shabrawey M, Bartoli M, El-Remessy AB, Ma G, Matragoon S, Lemtalsi T, Caldwell RW, Caldwell RB.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3231-8. doi: 10.1167/iovs.08-1754. Epub 2008 Mar 31.

25.

Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.

Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB.

Diabetes. 2008 Apr;57(4):889-98. doi: 10.2337/db07-1669. Epub 2008 Feb 19.

26.

Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.

Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI.

Ophthalmic Res. 2007;39(2):69-75. Epub 2007 Feb 2.

PMID:
17284931
27.

Simvastatin improves diabetes-induced coronary endothelial dysfunction.

Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW.

J Pharmacol Exp Ther. 2006 Oct;319(1):386-95. Epub 2006 Jul 18.

PMID:
16849625
28.

Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

Al-Shabrawey M, Bartoli M, El-Remessy AB, Platt DH, Matragoon S, Behzadian MA, Caldwell RW, Caldwell RB.

Am J Pathol. 2005 Aug;167(2):599-607.

29.

Alternative splicing of the APC gene in the neural retina and retinal pigment epithelium.

Liou GI, Samuel S, Matragoon S, Goss KH, Santoro I, Groden J, Hunt RC, Wang F, Miller SS, Caldwell RB, Rustgi AK, Singh H, Marcus DM.

Mol Vis. 2004 Jun 14;10:383-91.

30.

Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.

El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K, Liou GI.

Am J Pathol. 2003 Nov;163(5):1997-2008.

31.

MAP kinase and beta-catenin signaling in HGF induced RPE migration.

Liou GI, Matragoon S, Samuel S, Behzadian MA, Tsai NT, Gu X, Roon P, Hunt DM, Hunt RC, Caldwell RB, Marcus DM.

Mol Vis. 2002 Dec 20;8:483-93.

32.

HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.

Liou GI, Pakalnis VA, Matragoon S, Samuel S, Behzadian MA, Baker J, Khalil IE, Roon P, Caldwell RB, Hunt RC, Marcus DM.

Mol Vis. 2002 Dec 20;8:494-501.

33.
34.

Early onset photoreceptor abnormalities induced by targeted disruption of the interphotoreceptor retinoid-binding protein gene.

Liou GI, Fei Y, Peachey NS, Matragoon S, Wei S, Blaner WS, Wang Y, Liu C, Gottesman ME, Ripps H.

J Neurosci. 1998 Jun 15;18(12):4511-20.

35.

Visual sensitivity and interphotoreceptor retinoid binding protein in the mouse: regulation by vitamin A.

Liou GI, Matragoon S, Chen DM, Gao CL, Zhang L, Fei Y, Katz ML, Stark WS.

FASEB J. 1998 Jan;12(1):129-38.

PMID:
9438418
36.

Simple and efficient method for the preparation of nuclear extracts.

Fei Y, Matragoon S, Liou GI.

Biotechniques. 1995 Jun;18(6):984-7. No abstract available.

PMID:
7546723
37.
38.

Precocious IRBP gene expression during mouse development.

Liou GI, Wang M, Matragoon S.

Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1083-8. Retraction in: Invest Ophthalmol Vis Sci. 1994 Jul;35(8):3127.

PMID:
7510271
39.
40.

A simple method to homogenize multiple tissue samples in small sizes without cross contamination.

Liou GI, Matragoon S.

Biotechniques. 1992 Nov;13(5):719. No abstract available.

PMID:
1329859
41.

Retina-specific expression from the IRBP promoter in transgenic mice is conferred by 212 bp of the 5'-flanking region.

Liou GI, Matragoon S, Yang J, Geng L, Overbeek PA, Ma DP.

Biochem Biophys Res Commun. 1991 Nov 27;181(1):159-65.

PMID:
1958183
42.

Tissue-specific expression in transgenic mice directed by the 5'-flanking sequences of the human gene encoding interphotoreceptor retinoid-binding protein.

Liou GI, Geng L, al-Ubaidi MR, Matragoon S, Hanten G, Baehr W, Overbeek PA.

J Biol Chem. 1990 May 25;265(15):8373-6.

43.

Hemoglobin Suan-Dok (alpha 2 109 (G16) Leu replaced by Arg beta 2): an unstable variant associated with alpha-thalassemia.

Sanguansermsri T, Matragoon S, Changloah L, Flatz G.

Hemoglobin. 1979;3(2-3):161-74.

PMID:
478977

Supplemental Content

Loading ...
Support Center